Scientists test 'T cell Engager' to fight deadly brain tumors
Disease control
Not yet recruiting
This is a first-in-human study to test the safety of a new drug called BRiTE in adults with a specific, aggressive form of brain cancer (glioblastoma). The drug is designed to guide the patient's own immune cells to attack the tumor. The study will enroll up to 18 patients whose …
Phase: PHASE1 • Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC